TCL Archive Minority Based CCOP RFA Generate Wide Interest; 44 Letters Of Intent Received for Eight Awards September 1, 1989
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive With NIH “Accountability” As Background, Advocates Support Budget Increases. March 30, 2001
